Clinical Efficacy and Safety of Imatinib in the Management of Ph+ Chronic Myeloid or Acute Lymphoblastic Leukemia in Chinese Patients
OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s38846
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2014
Authors
Publisher
Informa UK Limited